RT Journal Article
SR Electronic
T1 Modulation of premotor cortex response to sequence motor learning during escitalopram-intake
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.19.20105346
DO 10.1101/2020.05.19.20105346
A1 Eóin N. Molloy
A1 Karsten Mueller
A1 Nathalie Beinhölzl
A1 Maria Blöchl
A1 Fabian A. Piecha
A1 André Pampel
A1 Christopher J. Steele
A1 Ulrike Scharrer
A1 Gergana Zheleva
A1 Ralf Regenthal
A1 Bernhard Sehm
A1 Vadim V. Nikulin
A1 Harald E. Möller
A1 Arno Villringer
A1 Julia Sacher
YR 2020
UL http://medrxiv.org/content/early/2020/05/22/2020.05.19.20105346.abstract
AB The contribution of selective serotonin reuptake inhibitors (SSRIs) to motor learning by inducing motor cortical plasticity remains controversial given diverse findings from positive preclinical data to negative findings in recent clinical trials. To empirically address this translational disparity, we use functional magnetic resonance imaging (fMRI) in a double-blind, randomized controlled study powered to assess whether 20 mg escitalopram improves sequence-specific motor performance and modulates cortical motor response in 64 healthy female participants. We found decreased left premotor cortex responses during sequence-specific learning performance comparing single dose and steady escitalopram state. Escitalopram plasma-levels negatively correlated with the premotor cortex response. We did not find evidence in support of improved motor performance after a week of escitalopram-intake. These findings do not support the conclusion that 1-week escitalopram intake increases motor performance but could reflect early adaptive plasticity with improved neural processing underlying similar task performance when steady peripheral escitalopram levels are reached.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT03162185Funding StatementThis research was supported by the FAZIT Foundation to ENM and The Branco Weiss Fellowship - Society in Science to JS and the Max Planck Society.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A